microRNA 6798 (MIR6798)

microRNA 6798 (MIR6798, hsa-mir-6798) is a predicted or very low-evidence microRNA locus in the human genome. There is currently no robust experimental validation, peer-reviewed literature, or reference in comprehensive microRNA databases describing its mature sequence, target genes, biological function, disease association, or pharmacological relevance. As a member of the microRNA family, it would, in principle, be expected to function in post-transcriptional regulation of gene expression if confirmed as valid, but there is no evidence that MIR6798 is expressed or functional in human tissues. Therefore, MIR6798 cannot be considered a proven molecular target, biomarker, or therapeutic entity as of the current scientific knowledge. Additional context and rationale: - Major microRNA reviews, databases, and molecular cancer studies do not mention MIR6798, although they do list and functionally characterize hundreds of established human microRNAs, especially those implicated in disease or targeted by drugs. - Most miRNA-based research and therapeutic development involves well-characterized miRNAs (e.g., miR-21, miR-155, miR-34a). The absence of MIR6798 from these resources strongly indicates it is not currently an established research or drug development target. - If MIR6798 is referenced in secondary annotation sources, it may represent a predicted locus lacking evidence of transcription, processing, or biological activity. Summary: There is no established scientific information on microRNA 6798 (MIR6798; hsa-mir-6798) as a biological entity, target, biomarker, or therapeutic molecule. It appears to be a predicted or uncharacterized microRNA without experimental validation or disease relevance.

Other names

hsa-mir-6798MIR6798microRNA mir-6798